A Standardized Intervention to Improve the Management of Chemotherapy-induced Nausea and Vomiting
Squamous Cell Carcinoma of Head and Neck, Chemotherapy Induced Nausea and Vomiting
About this trial
This is an interventional supportive care trial for Squamous Cell Carcinoma of Head and Neck
Eligibility Criteria
Inclusion Criteria: diagnosed with head and neck squamous cell carcinoma receive first cycle of chemotherapy receive cisplatin-based chemotherapy able to read and write. Exclusion Criteria: experience nausea or vomiting in 24 hours before receiving chemotherapy mental disturbance disturbance of consciousness history of stomach disease or surgery.
Sites / Locations
- Tianjin medical universtiy cancer institute and hospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
The intervention group
The control group
The intervention group will receive evidence-based, nurse-led standardized management of CINV, including nurse-led risk assessment, education on prevention and control of CINV, antiemetics following guidelines, dietary strategies, relaxation therapy, and follow up.
The control group will receive the routine CINV management. Patients are given drugs to prevent and control emesis according to the physicians' individual prescriptions. Nurses provide related education about nausea and vomiting control and recommend patients to drink more water and eat light food. Patients will be given Metoclopramide when they are vomiting.